Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD4+ and CD8+ T cell–dependent antiviral immunity requires STIM1 and STIM2
Patrick J. Shaw, Carl Weidinger, Martin Vaeth, Kevin Luethy, Susan M. Kaech, Stefan Feske
Patrick J. Shaw, Carl Weidinger, Martin Vaeth, Kevin Luethy, Susan M. Kaech, Stefan Feske
View: Text | PDF
Research Article

CD4+ and CD8+ T cell–dependent antiviral immunity requires STIM1 and STIM2

  • Text
  • PDF
Abstract

Calcium signaling is critical for lymphocyte function, and intracellular Ca2+ concentrations are regulated by store-operated Ca2+ entry (SOCE) through Ca2+ release–activated Ca2+ (CRAC) channels. In patients, loss-of-function mutations in CRAC channel components ORAI1 and STIM1 abolish SOCE and are associated with recurrent and chronic viral infections. Here, using mice with conditional deletion of Stim1 and its homolog Stim2 in T cells, we determined that both components are required for the maintenance of virus-specific memory CD8+ T cells and recall responses following secondary infection. In the absence of STIM1 and STIM2, acute viral infections became chronic. Early during infection, STIM1 and STIM2 were required for the differentiation of naive CD8+ T cells into fully functional cytolytic effector cells and mediated the production of cytokines and prevented cellular exhaustion in viral-specific CD8+ effector T cells. Importantly, memory and recall responses by CD8+ T cells required expression of STIM1 and STIM2 in CD4+ T cells. CD4+ T cells lacking STIM1 and STIM2 were unable to provide “help” to CD8+ T cells due to aberrant regulation of CD40L expression. Together, our data indicate that STIM1, STIM2, and CRAC channel function play distinct but synergistic roles in CD4+ and CD8+ T cells during antiviral immunity.

Authors

Patrick J. Shaw, Carl Weidinger, Martin Vaeth, Kevin Luethy, Susan M. Kaech, Stefan Feske

×

Figure 2

STIM1 and STIM2 regulate the function and differentiation of effector CD8+ cells.

Options: View larger image (or click on image) Download as PowerPoint
STIM1 and STIM2 regulate the function and differentiation of effector CD...
(A) CD8+ cytotoxic CTLs from DKO P14 or WT P14 mice were cocultured with peptide-pulsed EL-4 cells; apoptosis was detected by annexin V staining. (B) Splenic CD8+ T cells from LCMVARM-infected WT (n = 6) and DKO (n = 5) mice were stimulated with PMA/ionomycin (iono) or GP33–41 peptide for 6 hours and IFN-γ production determined by flow cytometry. (C) Apoptosis and proliferation of LCMV-specific WT (n = 6) and DKO (n = 5) CD8+ T cells analyzed by annexin V and Ki67 staining. (D) T-bet and Eomes expression in CD8+ T cells from 3 mice per group. (E–H) Mixed BM chimeras were generated by reconstituting Rag2–/– mice with BM from WT (CD45.1) and DKO (CD45.2) mice and infected with LCMVARM (E). Frequency (F and G) and total number (H) of splenic effector CD8+ T cells of WT or DKO origin. Each dot in G represents 1 WT:DKO chimera; horizontal lines represent mean cell percentages. (I and J) Congenic CD45.1 WT mice were infected with LCMVARM and injected with 5 × 104 CD8+ T cells from DKO P14 and WT P14 mice. (J) Left panels show percentages of DbGP33–41 tetramer+ CD8+ T cells; right panels show percentages of transferred versus host cells among LCMV-specific cells. Plots are representative of 4 mice per group. Statistical significance was calculated using Student’s t test (*P < 0.05; **P < 0.01; ***P < 0.001). Bar graphs in A–D and H represent the means ± SEM. Numbers in F and J represent the percentage of cells.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts